Positive Brugada Challenge Test in V1R–V3R as a Predictor of Malignant Prognosis in Brugada Patients

摘要

The Brugada syndrome is a heterogeneous genetic disease that predisposes to life‐threatening ventricular tachyarrhythmias and sudden cardiac death (SCD). The only proven way to prolong the survival of patients with Brugada syndrome is to implant an implantable cardioverter‐defibrillator (ICD). This should be implanted for high‐risk patients only.